Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05974800
Other study ID # 10842
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 2, 2024
Est. completion date July 1, 2024

Study information

Verified date February 2024
Source Erasmus Medical Center
Contact Jason den Duijn
Phone +31107040704
Email j.denduijn@erasmusmc.nl
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The goal of this Single center prospective cross-sectional study is to identify the facilitators and barriers among caregivers in the emergency department that influence disposition of patients with solid and hematology malignancies. The main question it aims to answer is to categorize the facilitators and barriers identified by three groups of emergency department (ED) staff. Participants will be asked for permission, afterwards a short interview will be held with the different ED caregivers (ED nurse, attending physician and supervising physician).


Description:

The goal of this to identify the facilitators and barriers among caregivers in the emergency department (ED) that influence disposition of patients with solid and hematology malignancies. Participants will be asked for permission, afterwards a short interview will be held with the different caregivers (ED nurse, attending physician and supervising physician) in the ED. The interviews will be held in the order of the ED care pathway, meaning ED nurse first, treating physician second and supervising physician at last. The interviews will be conducted for every patient with each of the caregivers. Each interview will be conducted after the caregiver has made the first examination of the patient. The interview focuses on several parts of the emergency care process: The first part is regarding the actions that are executed during an ED visit. We will establish which actions are executed and why. The second part is regarding the suspected outcome for the patient. The third part will be about any potential improvements to the emergency care process for the patient.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date July 1, 2024
Est. primary completion date May 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with solid or hematological malignancies and receiving system therapy or having received systemic therapy within the last 3 months. - Presented at or admitted from the emergency department for the oncology, hematology, neuro- or lung-oncology clinical unit. - Awake and conscious. - Possible to answer questions within the same shift / day after presentation in the ED. Exclusion Criteria: - <18 years old. - Only received a surgical intervention as cancer treatment. - Not willing or able to give written informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Emergency department caregivers interview
The interview focuses on several parts of the emergency care process: The first part is regarding the actions that are executed during an emergency department visit. We will establish which actions are executed and why. The second part is regarding the suspected outcome for the patient. The third part will be about any potential improvements to the emergency care process for the patient.

Locations

Country Name City State
Netherlands Erasmus MC Rotterdam Zuid-Holland

Sponsors (1)

Lead Sponsor Collaborator
Erasmus Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other Patient characteristics age, sex, type of cancer, type of treatment, main complaint, triage category, number of prior ED visits. Through study completion, an average of 6 months
Primary Clusters of facilitator and barriers identified by the emergency department (ED) nurse (Sub)Clusters of facilitator and barriers identified by the ED nurse for the ED care of patients with cancer Through study completion, an average of 6 months
Primary Clusters of facilitator and barriers identified by the treating physician (Sub)Clusters of facilitator and barriers identified by the treating physician for the ED care of patients with cancer Through study completion, an average of 6 months
Primary Clusters of facilitator and barriers identified by the supervising physician (Sub)Clusters of facilitator and barriers identified by the supervising physician for the ED care of patients with cancer Through study completion, an average of 6 months
Secondary Emergency department (ED) length of stay (LOS) Emergency department length of stay Through study completion, an average of 6 months
Secondary Disposition Outcome after ED admission, being home or admission Through study completion, an average of 6 months
Secondary Correlation between ED-LOS and disposition Correlation between ED-LOS and disposition Through study completion, an average of 6 months
Secondary Years of medical experience Number of years a medical staffmember is working in health care Through study completion, an average of 6 months
Secondary Need for imaging Was imaging ordered during ED visit and which kind Through study completion, an average of 6 months
Secondary ED nurse agreement of disposition Agreement between ED nurse expected disposition and the actual disposition Through study completion, an average of 6 months
Secondary Attending physician agreement of disposition Agreement between treating physician expected disposition and the actual disposition Through study completion, an average of 6 months
Secondary Supervising physician agreement of disposition Agreement between supervising physician expected disposition and the actual disposition Through study completion, an average of 6 months
Secondary Time-to-disposition The time between patient's arrival at the ED and the decision to disposition Through study completion, an average of 6 months
Secondary Time-to-ward The time between the decision to hospitalize and the arrival at the ward Through study completion, an average of 6 months
Secondary Correlation between time-to-disposition and the ED-LOS Correlation between time-to-disposition and the ED-LOS Through study completion, an average of 6 months
Secondary Correlation between time-to-ward and the ED-LOS Correlation between time-to-ward and the ED-LOS Through study completion, an average of 6 months
Secondary Difference in categories The difference in the percentages in categories between the different caregivers Through study completion, an average of 6 months
Secondary ED nurse summary of actions Summary of actions taken by ED nurse in the ED care for patients with cancer Through study completion, an average of 6 months
Secondary Attending physician summary of actions Summary of actions taken by attending physician in the ED care for patients with cancer Through study completion, an average of 6 months
Secondary Supervising physician summary of actions Summary of actions taken by supervising physician in the ED care for patients with cancer Through study completion, an average of 6 months
Secondary ED crowding Degree of crowding in the ED, consisting of number of patients in the ED and the ED crowding color code Through study completion, an average of 6 months
Secondary Difference in clusters per group between day, evening and night Difference in clusters per ED staff group between day, evening and night Through study completion, an average of 6 months
Secondary Difference in clusters per group between weekdays and weekend Difference in clusters per group between weekdays (Monday 08:00 till Friday 16:00) and weekend (Friday 16:01 till Monday 7:59) Through study completion, an average of 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients